 |
|
 |
 |

Home > Company Index > Energy > Oil & Gas Services > Enchira Biotechnology Corporation
 |
Enchira Biotechnology Corporation |
 |
 |
 |
PROFILE |
 |
Enchira Biotechnology does the DNA Shuffle. The company's technology improves DNA, genes, and proteins through resequencing for pharmaceutical, agricultural, and industrial markets. Licensee Genencor International is using the technology to develop improved industrial enzymes, while the firm itself is using the method to develop proteins to fight breast cancer with its partner, the M.D. Anderson Cancer Center at the University of Texas. Enchira would like to "RACHITT" up its activities, but one-time dance partner Maxygen is holding out. The two firms developed RACHITT, a key part of the gene shuffling technology, but are disputing rights to it; the outcome of the dispute may limit Enchira's use and licensing rights.
COMPETITION |
 |
Applied Molecular Evolution, Inc. (AMEV)
Diversa Corporation (DVSA)
Maxygen, Inc. (MAXY)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 0.80
1-Yr. Sales Growth: (42.9)%
Employees: 33
Revenue per employee: $24,242.42
KEY PEOPLE |
 |
Peter P. Policastro
CEO
Paul G. Brown
CFO
CONTACT INFO |
 |
4200 Research Forest Dr.
The Woodlands, TX 77381
US
Phone: 281-419-7000
Fax: 281-364-6112
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |